Yes, orchitis can cause infertility, though the risk depends heavily on the cause, whether one or both testicles are affected, and how quickly it’s treated. Most men with unilateral (one-sided) orchitis recover their fertility, but bilateral cases carry a significantly higher risk, with 30% to 87% of men experiencing infertility after bilateral mumps orchitis.
How Orchitis Damages Fertility
Orchitis disrupts fertility through several overlapping mechanisms. The testicles have a specialized protective system called the blood-testis barrier, which normally keeps immune cells away from developing sperm. When orchitis causes inflammation, this barrier breaks down. The immune system then encounters sperm cells for the first time and can treat them as foreign invaders, producing anti-sperm antibodies that attack and destroy sperm. This autoimmune response can persist long after the infection itself has cleared.
Inflammation also floods the testicle with toxic signaling molecules that directly interfere with sperm production. Over time, this can reduce how many sperm the testicle makes (oligospermia), eliminate sperm production entirely (azoospermia), or impair sperm movement (asthenospermia).
When orchitis is caused by bacterial infections, particularly sexually transmitted infections or urinary tract bacteria like E. coli, the damage often extends beyond the testicle itself. Bacteria can travel up through the reproductive tract, causing intense inflammation in the epididymis, the coiled tube where sperm mature and are stored. This inflammation leads to scarring that can physically block sperm from reaching the ejaculate. Among men with obstructive azoospermia (a complete absence of sperm due to a blockage), 22% to 47% of cases have an infectious origin. In acute bacterial epididymitis specifically, post-infectious azoospermia develops in up to 10% of cases.
Testicular Atrophy After Orchitis
One of the most visible long-term consequences is testicular atrophy, where the affected testicle permanently shrinks. This occurs in 40% to 70% of testicles affected by mumps orchitis. The shrinkage reflects actual loss of the tissue that produces sperm, and it typically becomes detectable on ultrasound between 25 and 230 days after the initial diagnosis, with an average of about 96 days. In fertility evaluations, testicular atrophy is strongly associated with azoospermia. It’s one of the clearest signs that orchitis has caused lasting damage to sperm production.
Mumps Orchitis Carries the Highest Risk
Mumps remains the most well-studied cause of orchitis-related infertility. Among post-pubertal men who contract mumps, 20% to 30% develop orchitis, and of those, 10% to 30% have both testicles affected. The distinction between one-sided and two-sided involvement is critical for fertility outcomes.
Unilateral mumps orchitis typically causes a temporary dip in sperm count, motility, and morphology that often recovers over time. The healthy testicle compensates. Overall, about 13% of all mumps orchitis patients experience some degree of fertility impairment. But when both testicles are inflamed, the numbers shift dramatically: 30% to 87% of men with bilateral mumps orchitis experience infertility. True sterility (a complete and permanent inability to father children) is rare even in these cases, but significant subfertility is common.
Bacterial Orchitis and Epididymitis
Bacterial orchitis, often occurring alongside epididymitis, poses a different kind of threat. Rather than attacking sperm production directly the way mumps does, bacterial infections primarily cause scarring. Pathogens ascend through the urogenital tract and trigger intense local inflammation. As this heals, scar tissue can obstruct the epididymis, the vas deferens, or the ejaculatory ducts. The result is that the testicle may still produce sperm normally, but the sperm have no way to exit the body.
This is an important distinction because obstructive causes of infertility are generally more treatable than damage to sperm production itself. However, the obstruction can sometimes become permanent. Even after successful antibiotic treatment of the infection, scarring may leave reduced sperm quality or complete azoospermia that doesn’t resolve on its own. Some research has found that even when standard semen analysis looks normal after recovery from epididymitis, significant changes in sperm protein composition persist, potentially affecting fertility in subtler ways.
Recovery Timeline
There is no single recovery timeline because outcomes depend on the severity of inflammation and the extent of damage. For unilateral mumps orchitis, sperm parameters often improve over several months as the unaffected testicle compensates. Testicular atrophy, when it occurs, typically declares itself within the first three to eight months.
For bacterial orchitis and epididymitis, the picture is more variable. If scarring causes obstruction, sperm may not return to the ejaculate even after the infection clears. In some cases, recovery is delayed by months or longer. Repeat semen analyses over time are generally needed to determine whether the damage is temporary or permanent.
Fertility Options After Orchitis
For men left with severely reduced or absent sperm after orchitis, assisted reproduction techniques offer a realistic path to biological fatherhood. Microdissection testicular sperm extraction (microTESE) involves surgically retrieving sperm directly from testicular tissue, bypassing any obstruction and finding pockets of sperm production even in atrophied testicles. The retrieved sperm are then used with a technique called ICSI, where a single sperm is injected directly into an egg.
Outcomes for men with mumps orchitis undergoing this approach are encouraging. In a study of 101 mumps orchitis patients treated with microTESE-ICSI, the fertilization rate was 66%, the pregnancy rate (positive pregnancy test) was 80%, and the live birth rate was 25%, comparable to men with other causes of non-obstructive azoospermia. These results suggest that even when orchitis has severely impaired natural fertility, viable sperm can often still be found and used successfully.
Early treatment of orchitis may also help preserve fertility. Some evidence suggests that men treated with anti-inflammatory medications during the acute phase of mumps orchitis show better semen quality at follow-up compared to those who weren’t treated, though this hasn’t been confirmed in large trials. Reducing the duration and intensity of inflammation is the general principle: the less damage to testicular tissue and reproductive ducts, the better the long-term fertility outlook.